HER2-targeted monoclonal antibody linked to the cytotoxic payload MMAE. After binding HER2 on tumor cells, the ADC is internalized and the linker is cleaved to release MMAE, which disrupts microtubules to induce G2/M arrest and apoptosis; the antibody Fc can also mediate ADCC.